Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CSL Behring announces FDA approval of Privigen for the treatment of CIDP in adults

biospectrumasiaSeptember 18, 2017

Tag: CSL Behring , CIDP

PharmaSources Customer Service